GlassScriptPhysician profile
Jyothi Gella
NPI 1235124918
$5,741.66
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $994 · 2020: $1,373 · 2021: $2,527 · 2022: $847.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,066.24 | 2019-2022 | |
| Pfizer INC. | $704.60 | 2019-2022 | |
| Lilly USA, LLC | $458.77 | 2020-2022 | |
| Novo Nordisk INC | $349.55 | 2019-2022 | |
| Esperion Therapeutics, INC. | $338.77 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $330.95 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $313.83 | 2021 | |
| Amgen INC. | $298.00 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $226.70 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $201.85 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $192.78 | 2022 | |
| Allergan, INC. | $180.55 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $157.58 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $145.12 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $107.51 | 2019-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $98.60 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $97.39 | 2021-2022 | |
| Electromed, INC. | $96.49 | 2019-2021 | |
| Dexcom, INC. | $65.49 | 2021 | |
| Glaxosmithkline, LLC. | $51.62 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $47.78 | 2021 | |
| Abbott Laboratories | $46.88 | 2021-2022 | |
| Boston Scientific Corporation | $41.13 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $39.04 | 2021 | |
| Amarin Pharma, INC. | $27.53 | 2019 | |
| Nestle Healthcare Nutrition INC. | $15.80 | 2022 | |
| Preventice Services, LLC | $15.00 | 2021 | |
| Jazz Pharmaceuticals INC. | $13.11 | 2020 | |
| Sanofi Pasteur INC. | $13.00 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jyothi Gella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.